AC
Armistice Capital’s Immunovant IMVT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $83.2M | Buy |
5,200,000
+700,000
| +16% | +$11.2M | 1.44% | 6 |
|
|
2025
Q1 | $76.9M | Buy |
4,500,000
+629,414
| +16% | +$10.8M | 1.15% | 6 |
|
|
2024
Q4 | $95.9M | Buy |
3,870,586
+322,586
| +9% | +$7.99M | 1.31% | 6 |
|
|
2024
Q3 | $101M | Buy |
3,548,000
+151,091
| +4% | +$4.31M | 1.62% | 5 |
|
|
2024
Q2 | $89.7M | Buy |
3,396,909
+1,232,909
| +57% | +$32.5M | 1.13% | 6 |
|
|
2024
Q1 | $69.9M | Buy |
2,164,000
+728,000
| +51% | +$23.5M | 0.93% | 9 |
|
|
2023
Q4 | $60.5M | Buy |
1,436,000
+400,123
| +39% | +$16.9M | 0.83% | 20 |
|
|
2023
Q3 | $39.8M | Buy |
+1,035,877
| New | +$39.8M | 0.61% | 30 |
|